Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (PHIOW) Stock Overview
Explore Phio Pharmaceuticals Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
421.4K
P/E Ratio
-15.92
EPS (TTM)
$-1.13
ROE
-1.06%
PHIOW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Phio Pharmaceuticals Corp. (PHIOW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.92 and a market capitalization of 421.4K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.